Patients with a corrected ASD have a poorer prognosis than patients in a control group, especially in the presence of PAH, which confers an eightfold increased probability of functional limitations. In the Euroheart survey PAH was present in 12% of patients with a closed ASD. As PAH is a progressive disease, early diagnosis and treatment may improve outcome in these patients.